ANEB Anebulo Quarterly EPS earnings growth

Anebulo Pharma - graphic logo of issuer ANEB

Anebulo Pharmaceuticals (ANEB) develops antidotes for emergency THC intoxication relief, targeting the B2B medical segment. Quarterly earnings per share growth reflects current dynamics, with the value holding at 46.40. The absence of competitors in this niche promises stable patent income; however, the company is currently in the clinical trial stage and does not yet generate operating cash flow.

anebulo.com (ANEB) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 03/07/2026

Financial and market metric breakdowns for Anebulo Pharmaceuticals, Inc. (ANEB)

- market value and analyst target forecast:
Initial company analysis:Anebulo Pharmaceuticals
Flagship merchandise of anebulo.com

For Anebulo Pharmaceuticals (ANEB), which operates in the defensive addiction therapy sector, the quarterly growth rate of net income per share reflects the efficiency of drug commercialization regardless of GDP dynamics. This metric measures the percentage change in EPS between reporting periods, allowing investors to assess the business's resilience to regulatory shocks and the pace of capitalization following successful clinical phases.

Direct competitors

Indivior Corp (INDV) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Quarterly EPS earnings growth|Quarterly EPS earnings growth canopygrowth.com|Quarterly EPS earnings growth HITI|ACB (Aurora Cannabis, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACHV (Achieve Life Sciences, Inc)|Skye Bioscience (SKYE) - Earnings per share growth in annualized terms for the last twelve months|Canndoc - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Year-over-year earnings per share growth for the last twelve months|India Globalization Capital - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MIRA Pharma|FLGC: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months IMC (IMCC)|ADIL: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth ARTL (Artelo)|Year-over-year earnings per one share growth for the last 12 months ENSC|Titan Pharmaceuticals - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Greenlane Holdings|inmedpharma.com (INM) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AKAN|Year-over-year earnings per share growth for the last twelve months Enveric Corp|Earnings per share growth in annualized terms for the last twelve months brightgreen.us BGXX|Year-over-year net earnings per share growth for the last 12 months HPCO (Hempacco Co Inc.)